|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.205 USD | +3.32% |
|
+5.39% | -12.40% |
| Apr. 15 | Sector Update: Health Care Stocks Gain Monday Afternoon | MT |
| Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |  |
SEOUL, Jan 12 (Reuters) - South Korea has authorised use of Novavax Inc's COVID-19 vaccine, the food and drug safety ministry said on Wednesday.
It joins the ranks of authorised vaccines made by AstraZeneca Inc, Moderna Inc, Pfizer and Johnson & Johnson's Janssen.
(Reporting by Heekyong Yang and Joyce Lee; Editing by Clarence Fernandez)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 11,394 GBX | +1.12% | +4.84% | 217B | ||
| 107.9 USD | +3.28% | +3.95% | 41.31B | ||
| 26.32 USD | +0.23% | +2.45% | 149B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -12.40% | 586M | |
| +3.13% | 43.43B | |
| +48.04% | 41.69B | |
| +8.49% | 41.31B | |
| -10.82% | 27.14B | |
| +8.26% | 25.28B | |
| -23.69% | 18.47B | |
| +1.58% | 12.33B | |
| +32.83% | 12.59B | |
| +6.63% | 11.03B |
NOVAVAX, INC. 
